Novo Nordisk has been outgained by a smaller and local pharma rival

Zealand Pharma has risen 63% in market value on the Copenhagen stock exchange this year compared with 40% for its larger and much more famous peer.

Related Keywords

Copenhagen ,Køavn ,Denmark ,Danish ,Novo Wegovy ,Boehringer Ingelheim Gmb ,Adam Steensberg ,Daniel Drucker ,Van Lanschot Kempen ,Rajan Sharma ,Michael Shah ,Zealand Pharma ,Suzanne Van Voorthuizen ,Stoxx Europe ,Eli Lilly Co ,Goldman Sachs Group Inc ,Bloomberg ,Eli Lilly ,Boehringer Ingelheim ,Bloomberg Intelligence ,Chief Executive Officer Adam Steensberg , ,